A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00529503
Recruitment Status : Terminated
First Posted : September 14, 2007
Last Update Posted : February 25, 2015
Genentech, Inc.
Information provided by (Responsible Party):
Seattle Genetics, Inc.